Physicians' Academy for Cardiovascular Education
PCSK9 inhibition & Cardiovascular Outcomes:  Review of lipid targets and treatment strategies

PCSK9 inhibition & Cardiovascular Outcomes: Review of lipid targets and treatment strategies

Aug. 25, 2017 - Barcelona, Spain

Saturday, August 26, 2017

Agenda

The Educational objectives are to:

CME Accreditation

This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

In compliance with EBAC guidelines, all speakers/Chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities

Funding

Supported by unrestricted educational grant from Amgen and Sanofi/Regeneron

Register

Please pre-register if you wish to attend the symposium. All participants should be registered for the ESC 2017 congress via the ESC

Register for symposium